Familial pancreatic cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Inherited genetic changes, from high-penetrance mutations to common genetic variants of modest effect, play a significant role in pancreatic cancer risk both in the familial and nonfamilial forms of the disease. Approximately 20% of the familial clustering of pancreatic cancer is explained by inherited mutations in BRCA2, BRCA1, CDKN2A, PALB2, ATM, PRSS1, STK11, MLH1, MSH2, MHS6, and PMS2. Even among families without an identifiable germline mutation, the presence of a family history of pancreatic cancer is a strong risk factor for the development of pancreatic cancer. Given the substantial increased risk of pancreatic cancer associated with a family history, many clinical trials aimed at the early detection of pancreatic cancer in this population are underway. The goal of this chapter is to review the evidence supporting the importance of a family history of pancreatic cancer as a risk factor for pancreatic cancer and the clinical and pathological features of familial pancreatic cancer.

Original languageEnglish (US)
Title of host publicationPancreatic Cancer
PublisherSpringer New York
Pages553-572
Number of pages20
ISBN (Electronic)9781493971930
ISBN (Print)9781493971916
DOIs
StatePublished - Apr 11 2018

Fingerprint

Pancreatic Neoplasms
Mutation
Penetrance
Germ-Line Mutation
Early Detection of Cancer
Cluster Analysis
Clinical Trials
Population

Keywords

  • ATM
  • BRCA2
  • Familial pancreatic cancer
  • Inherited susceptibility

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Roberts, N., & Klein, A. (2018). Familial pancreatic cancer. In Pancreatic Cancer (pp. 553-572). Springer New York. https://doi.org/10.1007/978-1-4939-7193-0_78

Familial pancreatic cancer. / Roberts, Nicholas; Klein, Alison.

Pancreatic Cancer. Springer New York, 2018. p. 553-572.

Research output: Chapter in Book/Report/Conference proceedingChapter

Roberts, N & Klein, A 2018, Familial pancreatic cancer. in Pancreatic Cancer. Springer New York, pp. 553-572. https://doi.org/10.1007/978-1-4939-7193-0_78
Roberts N, Klein A. Familial pancreatic cancer. In Pancreatic Cancer. Springer New York. 2018. p. 553-572 https://doi.org/10.1007/978-1-4939-7193-0_78
Roberts, Nicholas ; Klein, Alison. / Familial pancreatic cancer. Pancreatic Cancer. Springer New York, 2018. pp. 553-572
@inbook{a44b070f47cd49d8a19e8404718dc10b,
title = "Familial pancreatic cancer",
abstract = "Inherited genetic changes, from high-penetrance mutations to common genetic variants of modest effect, play a significant role in pancreatic cancer risk both in the familial and nonfamilial forms of the disease. Approximately 20{\%} of the familial clustering of pancreatic cancer is explained by inherited mutations in BRCA2, BRCA1, CDKN2A, PALB2, ATM, PRSS1, STK11, MLH1, MSH2, MHS6, and PMS2. Even among families without an identifiable germline mutation, the presence of a family history of pancreatic cancer is a strong risk factor for the development of pancreatic cancer. Given the substantial increased risk of pancreatic cancer associated with a family history, many clinical trials aimed at the early detection of pancreatic cancer in this population are underway. The goal of this chapter is to review the evidence supporting the importance of a family history of pancreatic cancer as a risk factor for pancreatic cancer and the clinical and pathological features of familial pancreatic cancer.",
keywords = "ATM, BRCA2, Familial pancreatic cancer, Inherited susceptibility",
author = "Nicholas Roberts and Alison Klein",
year = "2018",
month = "4",
day = "11",
doi = "10.1007/978-1-4939-7193-0_78",
language = "English (US)",
isbn = "9781493971916",
pages = "553--572",
booktitle = "Pancreatic Cancer",
publisher = "Springer New York",

}

TY - CHAP

T1 - Familial pancreatic cancer

AU - Roberts, Nicholas

AU - Klein, Alison

PY - 2018/4/11

Y1 - 2018/4/11

N2 - Inherited genetic changes, from high-penetrance mutations to common genetic variants of modest effect, play a significant role in pancreatic cancer risk both in the familial and nonfamilial forms of the disease. Approximately 20% of the familial clustering of pancreatic cancer is explained by inherited mutations in BRCA2, BRCA1, CDKN2A, PALB2, ATM, PRSS1, STK11, MLH1, MSH2, MHS6, and PMS2. Even among families without an identifiable germline mutation, the presence of a family history of pancreatic cancer is a strong risk factor for the development of pancreatic cancer. Given the substantial increased risk of pancreatic cancer associated with a family history, many clinical trials aimed at the early detection of pancreatic cancer in this population are underway. The goal of this chapter is to review the evidence supporting the importance of a family history of pancreatic cancer as a risk factor for pancreatic cancer and the clinical and pathological features of familial pancreatic cancer.

AB - Inherited genetic changes, from high-penetrance mutations to common genetic variants of modest effect, play a significant role in pancreatic cancer risk both in the familial and nonfamilial forms of the disease. Approximately 20% of the familial clustering of pancreatic cancer is explained by inherited mutations in BRCA2, BRCA1, CDKN2A, PALB2, ATM, PRSS1, STK11, MLH1, MSH2, MHS6, and PMS2. Even among families without an identifiable germline mutation, the presence of a family history of pancreatic cancer is a strong risk factor for the development of pancreatic cancer. Given the substantial increased risk of pancreatic cancer associated with a family history, many clinical trials aimed at the early detection of pancreatic cancer in this population are underway. The goal of this chapter is to review the evidence supporting the importance of a family history of pancreatic cancer as a risk factor for pancreatic cancer and the clinical and pathological features of familial pancreatic cancer.

KW - ATM

KW - BRCA2

KW - Familial pancreatic cancer

KW - Inherited susceptibility

UR - http://www.scopus.com/inward/record.url?scp=85054048114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054048114&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-7193-0_78

DO - 10.1007/978-1-4939-7193-0_78

M3 - Chapter

AN - SCOPUS:85054048114

SN - 9781493971916

SP - 553

EP - 572

BT - Pancreatic Cancer

PB - Springer New York

ER -